Proband-NFL Analysis

By Nirosen Vijiaratnam and Huw Morris
View Published Code

Output Details

Description
Code used for the manuscript "Combining biomarkers for prognostic modelling of Parkinson’s disease" by Niro Viijaratnam and colleagues.
Identifier (DOI)
10.5281/zenodo.5525370
Tags
  • Biomarkers
  • GBA (Glucocerebrosidase)
  • Predictive models
Team
Team Hardy
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

  • User avatar fallback logo

    Nirosen Vijiaratnam

  • Huw Morris

    Collaborating PI: Team Hardy, 

    University College London

Related Research

Sample Collection and Measurement of Serum Neurofilament Light (NfL)

This protocol details the steps for the preparation of serum from human blood samples and the measurement of NfL concentration using the NF-Light Advantage kit on the HD-X Analyzer (Quanterix, Billerica, MA).

View Protocol

Diabetes and neuroaxonal damage in Parkinson’s disease

Our findings affirm Uyar et al's report of an association between PD-DM and more severe neuroaxonal damage. T2DM and PD share several pathological processes, in par mediated by hyperglycemia and possibly diabetic neuropathy.

View Article

Soluble Immune Factor Profiles in Blood and CSF Associated with LRRK2 Mutations and Parkinson’s Disease

This preprint explores immune factors in Parkinson's disease linked to LRRK2 mutations. Serum showed elevated SDF-1 alpha and TNF-RII levels in LRRK2 carriers, while CSF had reduced immune markers. PD patients displayed reduced CSF inflammation.

View Article
View More Outputs